SCHEMBL234447

SCHEMBL234447

CC(=C=O)C=O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17581097 0.71
SCHEMBL4836613 0.71
SCHEMBL28904220 0.69
SCHEMBL245062 0.69
SCHEMBL16863050 0.67
SCHEMBL8154956 0.67
SCHEMBL17581105 0.65
SCHEMBL11038370 0.65
SCHEMBL11769153 0.65
SCHEMBL28000754 0.65

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 66 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-105585953-A Preparation and using method of long-acting paint water repellent agent BEIJING NEATRITION TECH CO LTD 2016-05-18 CN claimed
CN-101274279-B Oxide catalyst, process for producing acrolein or acrylic acid and process for producing water-absorbent resin NIPPON CATALYTIC CHEM IND 2013-07-17 CN claimed
US-6166173-A Biodegradable polymers chain-extended by phosphates, compositions, articles and methods for making and using the same GUILFORD PHARMACEUTICALS INC. (US) 2000-12-26 US claimed
CN-115515956-B Benzimidazole derivative, and preparation method and medical application thereof 深圳信立泰药业股份有限公司 2024-06-25 CN disclosed
EP-4094778-B1 POLYMER LINKERS AND THEIR USES NOVACYTE THERAPEUTICS COMPANY LTD (CN) 2024-05-15 EP disclosed
CN-117903171-A Integrin inhibitors of a class of bicyclic derivatives 上海如凌生物医药有限公司 2024-04-19 CN disclosed
CN-116715671-A Application of alpha-chromene spiropiperidine compound in preparation of 5-hydroxytryptamine 2C receptor agonist 苏州大学 2023-09-08 CN disclosed
US-20230119152-A1 POLYMER LINKERS AND THEIR USES NOVACYTE THERAPEUTICS COMPANY., LTD (CN) 2023-04-20 US disclosed
US-11529422-B2 Polymer linkers and their uses NOVACYTE THERAPEUTICS COMPANY., LTD (CN) 2022-12-20 US disclosed
CN-115068475-A Application of alpha-chromene spiropiperidine compounds in preparation of 5-hydroxytryptamine 2C receptor agonists 苏州大学 2022-09-20 CN disclosed
US-20200155693-A1 POLYMER LINKERS AND THEIR USES NOVACYTE, INC. (US) 2020-05-21 US disclosed
US-6350464-B1 COMPOSITION FOR INTRAPERITONEAL ADMINISTRATION TO TREAT MAMMAL HAVING OVARIAN CANCER COMPRISING ANTINEOPLASTIC AGENT AND BIODEGRADABLE POLYPHOSPHOESTER POLYMER, PROVIDING EXTENDED RELEASE OF AGENT AND INCREASED SURVIVAL RATE GUILFORD PHARMACEUTICALS, INC. 2002-02-26 US disclosed
WO-2002004544-A2 POLYMERS AND POLYMERIZATION PROCESSES GUILFORD PHARMACEUTICALS (US) 2002-01-17 WO disclosed
WO-2002003957-A2 COMPOSITIONS FOR SUSTAINED RELEASE OF ANTINEOPLASTIC TAXANES, AND METHODS OF MAKING AND USING THE SAME GUILFORD PHARMACEUTICALS, INC. (US) 2002-01-17 WO disclosed
US-20010038849-A1 Methods for treating ovarian cancer, poly (phosphoester) compositions, and biodegradable articles for same EISAI INC. 2001-11-08 US disclosed
EP-1140028-A1 METHODS FOR TREATING OVARIAN CANCER, POLY(PHOSPHOESTER) COMPOSITIONS, AND BIODEGRADABLE ARTICLES FOR SAME GUILFORD PHARMACEUTICALS INC. (US) 2001-10-10 EP disclosed
US-6166173-A Biodegradable polymers chain-extended by phosphates, compositions, articles and methods for making and using the same GUILFORD PHARMACEUTICALS INC. (US) 2000-12-26 US disclosed
WO-2000041678-A1 METHODS FOR TREATING OVARIAN CANCER, POLY(PHOSPHOESTER) COMPOSITIONS, AND BIODEGRADABLE ARTICLES FOR SAME GUILFORD PHARMACEUTICALS INC. (US) 2000-07-20 WO disclosed
EP-0971969-A1 BIODEGRADABLE POLYMERS CHAIN-EXTENDED BY PHOSPHATES, COMPOSITIONS, ARTICLES AND METHODS FOR MAKING AND USING THE SAME GUILFORD PHARMACEUTICALS INC. (US) 2000-01-19 EP disclosed
WO-1998044020-A1 BIODEGRADABLE POLYMERS CHAIN-EXTENDED BY PHOSPHATES, COMPOSITIONS, ARTICLES AND METHODS FOR MAKING AND USING THE SAME GUILFORD PHARMACEUTICALS INC. (US) 1998-10-08 WO disclosed